The Readout LOUD-logo

The Readout LOUD

News & Politics Podcasts >

More Information

Location:

United States

Twitter:

@statnews

Language:

English


Episodes

Episode 32: Fake friends at the FDA, cancer counter-narratives, and biotech's bear turn

10/11/2018
More
Is the next big idea in oncology a bust? What does "successful" mean exactly? And why does Wall Street hate biotech all of a sudden?

Duration:00:22:47

Episode 31: Nobel snubs, millenial founders, and a new kind of lightning round

10/4/2018
More
Did the Nobel Prizes go to the right scientists? Why is there so much disdain for biotech's millenial entrepreneurs? And do journalists have a good taste in '80s music?

Duration:00:23:42

Episode 30: A fish oil epiphany, VC monopolies and ketamine clinics

9/27/2018
More
Was everyone wrong about fish oil? Is venture capital a cartel? And what's with all those ketamine clinics?

Duration:00:25:13

Episode 29: A Hong Kong heat-check, a $20 million wrist slap, and pharma's (other) diversity problem

9/20/2018
More
Is a biotech bubble inflating in China? Do the feds coddle CEOs? And why don't clinical trials look like America?

Duration:00:24:38

Episode 28: Founders' funds, doctors' disclosures, and the subtle art of beeping

9/13/2018
More
Is biotech too founder-friendly? Is honesty overrated? And how do you tell a good beep from a bad one?

Duration:00:22:57

Episode #9 - Bill Gates on deadly flu, Chinese biotech bubbles, Golden State killer genetics

5/3/2018
More
We talk to Bill Gates about the flu that could kill millions. Is China too enamored with biotech startups? And how do you find a cold case killer? Genetics.

Duration:00:27:36

Episode #8 - Megamergers, migraines, and biotech's Four Horsemen

4/26/2018
More
What's a good use of $64 billion? Is Big Biotech boring now? And what's the best way to sell hair restoration products to men?

Duration:00:25:04

Episode #7 - Coke and Pepsi of lung cancer, a debatable drug price, and a cure for capitalism

4/19/2018
More
Is Bristol-Myers Squibb into self-sabotage? Is Congress coming for Gut Guy? And why does Goldman Sachs love money so much?

Duration:00:21:55

Episode #6 - Biotech buyouts, CEO breakups, and The Rock does CRISPR

4/12/2018
More
Why are biotech investors suddenly so exuberant? What does it mean when a CEO scrubs his LinkedIn profile? And can CRISPR turn your dog into a winged hellhound bent on destroying Chicago?

Duration:00:23:33

Episode #5 - The FDA's cold shoulder, the latest CAR-T contender, and BuzzFeed's scoop on Grindr

4/5/2018
More
What's it like to be a biotech investor? Do you know where your genetic data are? And what does it mean when the FDA swipes left on your drug?

Duration:00:22:31

Episode #4 - Mr. Drug CEO doesn't go to DC, billionaires fighting drug prices, a biotech report card

3/29/2018
More
Why aren't pharma CEOs getting hauled into Congress? Which biotech companies got a failing grade this quarter? And why is there no Kelley Blue Book for the price tag of a medicine?

Duration:00:23:36

Episode #3 - A gene therapy story, breaking down Incyte’s future, and was Gottlieb wrong to try?

3/22/2018
More
What’s it like to watch gene therapy happen? Is the next big cancer clinical trial going to work? And is “right to try” going to defang the FDA?

Duration:00:24:46

Episode #2 - Theranos’s fate, biotech’s awkward SXSW, and a word on cow loogies

3/15/2018
More
Did Elizabeth Holmes get off easy? Why does biotech bother with SXSW? And what does shoving a tube into a dead cow’s throat have to do with biotech?

Duration:00:21:41

Episode #1 - Shkreli's sentence, biotech froth, and a blood party

3/8/2018
More
How long is Martin Shkreli going to be in prison? Is the biotech bubble about to burst? And what's it like to attend a blood-swapping gala? Listen to our first episode of, "The Readout LOUD."

Duration:00:18:23

Coming soon: "The Readout LOUD"

3/2/2018
More
An introduction to a new weekly biotech podcast from STAT.

Duration:00:01:15